Upload Records Snowball Search Search OpenAlex
About the database ScholarIQanswers from OpenAlex
Secondary analysis of the EMPACT-MI trial reveals cardiovascular–kidney efficacy and safety of empagliflozin after acute myocardial infarction
PaperCitations, authors & open-access status
Secondary analysis of the EMPACT-MI trial reveals cardiovascular–kidney efficacy and safety of empagliflozin after acute myocardial infarction is a paper indexed in ScholarIQ from OpenAlex. ScholarIQ records 3 citations, 2025 year and hybrid oa status.
3
Citations
2025
Year
hybrid
OA Status